Triad Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$804K Buy
6,686
+851
+15% +$98.2K 0.06% 200
2025
Q4
$614K Buy
5,835
+1,068
+22% +$100K 0.06% 224
2025
Q3
$400K Buy
4,767
+996
+26% +$82K 0.05% 238
2025
Q2
$299K Sell
3,771
-161
-4% -$12.8K 0.06% 217
2025
Q1
$353K Buy
3,932
+116
+3% +$10.8K 0.11% 138
2024
Q4
$380K Buy
+3,816
New +$393K 0.14% 115
2024
Q3
Sell
-2,593
Closed -$321K 581
2024
Q2
$321K Buy
2,593
+548
+27% +$70.6K 0.17% 60
2024
Q1
$270K Buy
+2,045
New +$252K 0.21% 47

Other funds holding MRK

Triad Wealth Partners's MRK Position: Q1 2026 in Review

Triad Wealth Partners increased its Merck (MRK) stake by 15% in Q1 2026, buying an estimated $98.2K and bringing the position to 6,686 shares worth $804K. The position accounts for 0.06% of the portfolio, ranked #200.

Triad Wealth Partners first reported a position in MRK in Q1 2024 and has held it in 8 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Triad Wealth Partners held 6,686 shares of Merck worth $804K as of Q1 2026.
  • Triad Wealth Partners bought 851 Merck shares in Q1 2026, an estimated $98.2K.
  • Merck made up 0.06% of Triad Wealth Partners's portfolio in Q1 2026, its #200 holding.
  • Triad Wealth Partners first reported a position in Merck in Q1 2024 and has held it in 8 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Triad Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.